- Home
- PHI vs ALKS Comparison
PHI vs ALKS Comparison
Compare PHI & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHI
- ALKS
- Stock Information
- Founded
- PHI 1928
- ALKS 1987
- Country
- PHI Philippines
- ALKS Ireland
- Employees
- PHI N/A
- ALKS N/A
- Industry
- PHI Telecommunications Equipment
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- PHI Telecommunications
- ALKS Health Care
- Exchange
- PHI Nasdaq
- ALKS Nasdaq
- Market Cap
- PHI 4.9B
- ALKS 5.7B
- IPO Year
- PHI 1953
- ALKS 1991
- Fundamental
- Price
- PHI $23.95
- ALKS $35.32
- Analyst Decision
- PHI
- ALKS Buy
- Analyst Count
- PHI 0
- ALKS 12
- Target Price
- PHI N/A
- ALKS $37.25
- AVG Volume (30 Days)
- PHI 58.0K
- ALKS 1.9M
- Earning Date
- PHI 03-26-2025
- ALKS 02-12-2025
- Dividend Yield
- PHI 7.09%
- ALKS N/A
- EPS Growth
- PHI 147.52
- ALKS 3.47
- EPS
- PHI 2.21
- ALKS 2.17
- Revenue
- PHI $3,846,163,485.00
- ALKS $1,557,632,000.00
- Revenue This Year
- PHI $4.15
- ALKS N/A
- Revenue Next Year
- PHI $4.20
- ALKS $4.67
- P/E Ratio
- PHI $10.79
- ALKS $16.05
- Revenue Growth
- PHI 3.33
- ALKS N/A
- 52 Week Low
- PHI $21.00
- ALKS $22.90
- 52 Week High
- PHI $30.39
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- PHI 68.55
- ALKS 71.72
- Support Level
- PHI $22.73
- ALKS $31.01
- Resistance Level
- PHI $24.10
- ALKS $36.45
- Average True Range (ATR)
- PHI 0.46
- ALKS 1.05
- MACD
- PHI 0.10
- ALKS 0.32
- Stochastic Oscillator
- PHI 90.63
- ALKS 81.57
About PHI PLDT Inc. Sponsored ADR
PLDT Inc is the telecommunications carrier in the Philippines. The company's business activities include three business units: Wireless, Fixed Line, and Others. The wireless segment consists of mobile telecommunications services provided by Smart and DMPI, and Fixed-line telecommunications services mainly provided by PLDT. It also provides fixed-line services through PLDT's subsidiaries.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.